Show an ad over header. AMP

Vaccine patents complicate efforts to scale manufacturing

Open-source the vaccines. That's the message being sent by the People's Vaccine Alliance, a coalition that includes Amnesty International, Oxfam, and UNAIDS.

Why it matters: Manufacturing capacity needs to be scaled up dramatically — and cutting out the need for laborious, expensive and secretive negotiations with vaccine patent holders could help.


What they're saying: "None of the manufacturers today are remotely capable of meeting demand on a timely basis," says Knowledge Ecology International's Jamie Love. "Vaccine manufacturers are currently hoarding technology, for commercial reasons."

By the numbers: Pfizer, Moderna and AstraZeneca are only expected to produce enough vaccine in 2021 to cover about 1.5% of the world's population.

  • Of the 108 million people vaccinated so far, only 4% have been in developing countries. Nearly all of those have been in India, where Oxford University ensured that the Serum Institute of India would be licensed to produce its vaccine at the same time that AstraZeneca received control of the intellectual property.
  • The global economy will lose $9 trillion if the developing world fails to receive timely access to vaccines, according to a study from the International Chamber of Commerce. Half of that cost will fall on rich countries.
  • According to the Alliance, there are at least 20 more facilities in India alone that could start producing vaccine, and many more in other countries such as Argentina, South Africa, Brazil, Mexico, and Indonesia.

The big picture: While Operation Warp Speed helped to stand up new manufacturing facilities in the U.S., there has been little to no such investment in most of the rest of the world.

  • "We need to build new capacity," says Oxfam's Niko Lusiani. "Even if it takes two years it will still be useful. For COVID-19, for future pandemics, and for future strains."
  • "Freeing up IP will unlock a lot of public and private investment into vaccine production."

Pfizer CFO Frank D'Amelio said on the company's earnings call this month that while "pandemic pricing" in the U.S. is $19.50 per dose, "a normal price that we typically get for a vaccine" would be $150 to $175 per dose.

  • The pandemic pricing gives Pfizer a profit margin of well over 20% — but D'Amelio said that "there's a significant opportunity for those margins to improve once we get beyond the pandemic environment" — when pricing will free up and factories become more efficient.

How it works: While international trade law does allow countries to overrule patent protection for vaccines, countries tend to be very reluctant to do so, because they fear retaliation and also because they need help with the technical knowhow involved in manufacturing the vaccines.

The other side: Opening up manufacturing to a point where the patent holders have no oversight could lead to quality-control issues.

  • Opponents of open-sourcing vaccines also say there's no evidence that there's a lot of spare manufacturing capacity.
  • China and Russia are also big unknowns. Both of them are likely to try to distribute their vaccines globally as a form of soft power.

Biden says it's "not the time to relax" after touring Houston COVID-19 vaccination site

President Biden said Friday that "it's not the time to relax" coronavirus mitigation efforts and warned that the number of cases and hospitalizations could rise again as new variants of the virus emerge.

Why it matters: Biden, who made the remarks after touring a vaccination site in Houston, echoed CDC director Rochelle Walensky, who said earlier on Friday that while the U.S. has seen a recent drop in cases and hospitalizations, "these declines follow the highest peak we have experienced in the pandemic."

Keep reading... Show less

Podcast: Airbnb CEO Brian Chesky on the future of travel and his company

Airbnb seems to be on the precipice of a business boom, as travel is expected to surge once herd immunity is achieved.

Axios Re:Cap speaks with CEO Brian Chesky about the company's first earnings report since going public, plus what's next for Airbnb, travel and hospitality.

Biden after U.S. airstrike: Iran "can't act with impunity. Be careful"

President Biden said Friday that Thursday night's airstrike against facilities tied to an Iranian-backed militia group in Syria was meant to warn Iran that it "can't act with impunity."

Driving the news: The Pentagon said the airstrike, which was authorized by Biden, was carried out "in response to recent attacks against American and Coalition personnel in Iraq" and was intended to "de-escalate the overall situation in both eastern Syria and Iraq."

Keep reading... Show less

Schiff: "Definitive" Khashoggi report sends clear message to Saudis

The report released Friday on the murder of Jamal Khashoggiwas short on evidence or new information, but Rep. Adam Schiff (D-Calif.) tells Axios that the “definitive” statement assigning responsibility to Saudi Crown Prince Mohammed bin Salman (MBS) speaks volumes.

What he’s saying: Schiff, the chairman of the House intelligence committee, says that while some intelligence couldn’t be published because of the need to protect sources and methods, “we rarely see something published that is this definitive and I think that's an important accomplishment for the administration.”

Keep reading... Show less

FDA advisory panel endorses Johnson & Johnson one-shot COVID vaccine for emergency use

A Food and Drug Administration advisory panel on Friday recommended the authorization of Johnson & Johnson’s one-shot coronavirus vaccine for emergency use.

Why it matters: The FDA is expected to make a final decision within days on the J&J vaccine, which was found to be 66% effective against moderate to severe COVID. An emergency use authorization would allow distribution to immediately begin, helping streamline and speed up the vaccine rollout across the U.S.

Keep reading... Show less

Law enforcement groups back Biden pick for associate attorney general

Local and federal law enforcement officials are backing Vanita Gupta, President Biden’s nominee for associate attorney general, according to letters sent to the Senate Judiciary Committee and obtained by Axios.

Why it matters: The Major County Sheriffs of America noted Gupta “emphasized that she does not support efforts to ‘defund the police'” and highlighted her desire to improve criminal justice through methods that include increased training for law enforcement officials.

Keep reading... Show less

About 20% of U.S. adults have received first COVID-19 vaccine dose, White House says

Nearly 1 in 5 adults and nearly half of Americans 65 and older have received their first dose of the coronavirus vaccine, White House senior adviser Andy Slavitt said on Friday.

The big picture: The Biden administration has previously said it has secured enough doses to vaccinate most of the American population by the end of July.

Keep reading... Show less

Insights

mail-copy

Get Goodhumans in your inbox

Most Read

More Stories